Garduño-García JJ, Pérez-Espejel I, Huitrón-Bravo G, Romero-Figueroa MS

Language: Spanish
References: 30
Page: 674-679
PDF size: 132.70 Kb.

ABSTRACT

Background: Osteoporosis-related fractures represent a major health problem. Although spine and hip bone densitometry is the gold standard to assess bone density, this test is not always accesible. The purpose of this study was to describe two options to assess the risk of fracture due to osteoporosis in post-menopausal women assigned to a primary care unit where bone densitometry is not available.
Methods: A cross-sectional study was conducted in 332 post-menopausal women without diagnosis or treatment for osteoporosis, attending regularly to a primary care unit. A heel bone peripheral densitometry, physical exam and medical history were performed. The assessment of fracture risk was carried out using the FRAX^™ method.
Results: Mean age was 60 ± 8.7 years and body mass index was 28.68 ± 4.24. According to the heel bone peripheral densitometry, 19 (5.7 %) women had osteoporosis (T-score less than or equal to –2.5), 171 (51.8 %) had osteopenia (T-score between –2.5 and less than or equal to –1) and 141 (42.5 %) had normal bone mineral density. According to the FRAX method, 13 (3.9 %) had an increased risk of osteoporotic fracture in a 10-year period and 40 (12 %) of hip fracture.
Conclusions: There was low concordance in the 10-year risk for major osteoporotic fracture and hip fracture assessed with both the FRAX^™ and the peripheral bone densitometry methods.

REFERENCES

1. Unnanuntana A, Gladnick BP, Donnelly E, Lane JM. The assessment of fracture risk. J Bone Joint Surg Am. 2010;92(3):743-53.

2. Dhanwal DK, Dennison EM, Harvey NC, Cooper C. Epidemiology of hip fracture: Worldwide geographic variation. Indian J Orthop. 2010;45(1):15-22. Texto libre en http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3004072/

3. Riera-Espinoza G. Epidemiology of osteoporosis in Latin America 2008. Salud Publica Mex. 2009;51 (Supl 1):S52-5. Texto libre en http://www.scielosp. org/scielo.php?script=sci_arttext&pid=S0036-3634 2009000700009&lng=en&nrm=iso&tlng=en

4. Blake GM, Fogelman I. An update on dual-energy X-ray absorptiometry. Semin Nucl Med. 2010.40(1): 62-73.

5. Hans D, Krieg MA. Quantitative ultrasound for the detection and management of osteoporosis. Salud Publica Mex. 2009;51(Supl 1): S25-37. Texto libre en http://www.scielosp.org/scielo.php?script=sci_ arttext&pid=S0036-36342009000700006&lng=en&nr m=iso&tlng=en

6. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2010;19(4):385-97. Texto libre en http://www.ncbi. nlm.nih.gov/pmc/articles/PMC2267485/

7. National Osteoporosis Foundation. Clinician guide to prevention and treatment of osteoporosis. J Clin Densitom. 2008;1:473-7.

8. Knapp KM. Quantitative ultrasound and bone health. Salud Publica Mex. 2009;51(Supl 1):S18-24. Texto libre en http://www.scielosp.org/scielo.php?script=sci_ arttext&pid=S0036-36342009000700005&lng=en& nrm=iso&tlng=en

9. Patel R, Blake GM, Fogelman I. Peripheral and central measurements of bone mineral density are equally strongly associated with clinical risk factors for osteoporosis. Calcif Tissue Int. 2007;80(2):89-96.

10. Gluer CC, Jergas M, Hans D. Peripheral measurement techniques for the assessment of osteoporosis. Semin Nucl Med. 1997;27(3):229-47. Rev Med Inst Mex Seguro Soc. 2014;52(6):674-9 679 Garduño-García JJ et al. Evaluación del riesgo de fractura osteoporótica

11. Hernández-Prado B, Lazcano-Ponce E, Cruz-Valdez A, Diaz R, Tamayo J, Hernández-Ávila M. Validity of bone mineral density measurements in distal sites as an indicator of total bone mineral density in a group of pre-adolescent and adolescent women. Arch Med Res. 2002;33(1):33-9.

12. Clark P, Lavielle P, Franco-Marina F, Ramírez E, Salmerón J, Kanis JA, et al. Incidence rates and lifetime risk of hip fractures in Mexicans over 50 years of age: A population-based study. Osteoporos Int. 2005;16(12):2025-30.

13. Velasco-Murillo V, Navarrete-Hernández E, Pozos- Cavanzos JL, Ojeda-Mijares RI, Camacho-Rodríguez Mde L. Fractures in postmenopausal women in the IMSS: Frequency and costs of hospital care. Gac Med Mex. 2003;139(5):453-8.

14. Morales-Torres J. Strategies for the prevention and control of osteoporosis in developing countries. Clin Rheumatol. 2007;26(2):139-43.

15. Frediani B, Acciai C, Falsetti P, Baldi F, Filippou G, Siagkri C, et al. Calcaneus ultrasonometry and dualenergy X-ray absorptiometry for the evaluation of vertebral fracture risk. Calcif Tissue Int. 2006;79(4):223-9.

16. Frost ML, Blake GM, Fogelman I. Quantitative ultrasound and bone mineral density are equally strongly associated with risk factors for osteoporosis. J Bone Miner Res. 2001;16(2):406-16.

17. Frost ML, Blake GM, Fogelman I. Can the WHO criteria for diagnosing osteoporosis be applied to calcaneal quantitative ultrasound? Osteoporos Int. 2000;11(4):321-30.

18. Blake GM, Chinn DJ, Steel SA, Patel R, Panayiotou E, Thorpe J, Fordham JN. A list of device-specifi c thresholds for the clinical interpretation of peripheral X-ray absorptiometry examinations. Osteoporos Int. 2005;16(12):2149-56.

19. De Lago-Acosta A, Parada-Tapia MG, Somera- Iturbide J. Osteoporosis prevalence in open population at Mexico City. Ginecol Obstet Mex. 2008;76(5): 261-6.

20. Rojano-Mejía D, Aguilar-Madrid G, López-Medina G, Cortés-Espinosa L, Hernández-Chiu MC, Canto- Cetina T, et al. Risk factors and impact on bone mineral density in postmenopausal Mexican mestizo women. Menopause. 2011;18:302-6.

21. Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, et al. The use of clinical risk factors enhances the performance of body mass index in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007;18(8):1033-46.

22. Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2008;19 (4):399-428. Texto libre en http://www.ncbi.nlm.nih. gov/pmc/articles/PMC2613968/

23. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause. 2010;17(1):25-4.

24. Dawson-Hughes B. National Osteoporosis Foundation Guide Committee. A revised clinician’s guide to the prevention and treatment of osteoporosis. J Clin Endocrinol Metab. 2008;93(7):2463-5.

25. Pressman AR, Lo JC, Chandra M, Ettinger B. Methods for assessing fracture risk prediction models: Experience with FRAX in a large integrated health care delivery system. J Clin Densitom. 2011;14(4):407-15. doi: 10.1016/j.jocd.2011.06.006. Epub 2011 Oct 1.

26. Latorre FG. Unidades de primer nivel de atención en los servicios estatales de salud. Evaluación 2008. En: Desempeño. Dirección General de Evaluación del Desempeño. México: Secretaría de Salud; 2009. p. 1-56.

27. Silverman SL, Calderón AD. The utility and limitations of FRAX: A US perspective. Curr Osteoporos Rep. 2010;8(4):192-7. Texto libre en http://www.ncbi. nlm.nih.gov/pmc/articles/PMC2947011/

28. Furuya T, Hosoi T, Saito S, Inoue E, Taniguchi A, Momohara S, et al. Fracture risk assessment and osteoporosis treatment disparities in 3,970 Japanese patients with rheumatoid arthritis. Clin Rheumatol. 2011; 30(8):1105-11.

29. Pedrazzoni M, Girasole G, Giusti A, Barone A, Pioli G, Passeri G, et al. Assessment of the 10-year risk of fracture in Italian postmenopausal women using FRAX(R): A North Italian Multicenter Study. J Endocrinol Invest. 2011;34(11):e386-91. doi:10.3275/7862. Epub 2011 Jul 12.

30. Nasser KM, Focil A, Silverman SL. Comparison of FRAX scores of Southern California females of Mexican descent using US Hispanic and Mexico database. J Osteoporos. 2011;2011:531359. doi: 10.4061/2011/531359. Epub 2011 May 25. Disponible en http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135157/